Comparations Of Glycated Albumin Among Type 2 Diabetes Mellitus Patient With Normoalbuminuria, Microalbuminuria And Macroalbuminuria

Raja Iqbal Mulya Harahap, Nina Tristina, Ruri Rizki Anriani

Abstract

Diabetic nephropathy is the most often complication of diabetes mellitus (DM). Complications of diabetic nephropathy can occur through several pathways, one of which is the formation of Advanced Glycation End Products (AGEs) through the formation of Glycated Albumin (GA). Glycated albumin (GA) is a medium-term glycemic control (2-3 weeks), shorter duration than HbA1c (2-3 months). The aim of this study was to compare the levels of GA in T2DM patients with normoalbuminuria, microalbuminuria, and macroalbuminuria. This is a cross-sectional study with subjects were 105 outpatients who had been diagnosed with T2DM by clinicians at Hasan Sadikin Hospital’s Endocrinology Clinic. We examined urinary albumin per Creatinine (u-ACR) and blood GA Increased GA level was found in 75.24% subjects. Kruskal Wallis test in GA serum levels of patients with T2DM normoalbuminuria group, microalbuminuria and macroalbuminuria revealed statistically significant (p <0.001), with median and range of GA in normoalbuminuria 15,9% (12,1-21,89)%; microalbuminuria 20,9% (12,9-47,2)%; dan macroalbuminuria 23,1% (13,6-46,1)%. Statistical analysis showed that the GA serum level was significantly different between T2DM patients with normoalbuminuria and macroalbuminuria, but not between those with microalbuminuria and macroalbuminuria (p=0.001 and p=0.137, respectively).  The result showed that the extensive kidney damage at the subject, the higher result of Glycated Albumin level in serum.

Keywords

Glycated Albumin, Type 2 Diabetes Mellitus, urinary Albumin per Creatinine Ratio

Full Text:

PDF

References

American Diabetes Association. Standards of medical care in diabetes. Diagnosis and classification of diabetes mellitus [serial on the Internet]. 2016; 39(S1).

Ritz E, Schmieder RE, Pollock CA. Renal protection in diabetes: lessons from ONTARGET. Cardiovasc Diabetol. 2014 Oct 1;9:60. doi: 10.1186/1475-2840-9-60.

Fineberg D, Jandeleit-Dahm KA, Cooper ME. Diabetic nephropathy: diagnosis and treatment. Nature reviews Endocrinology. 2013 Dec; 9(12):713-23.

Onoa T, Kenichi Shikataa, Obikac M, Nobuyuki Miyataked, Koderaa R, Hirotaa D. Factors associated with remission and/or regression of mic- roalbuminuria in type 2 diabetes mellitus. Acta Med Okayama. 2014;68(4):235-41.

Anguizola J, Matsuda R, Barnaby OS, Hoy KS, Wa C, DeBolt E, et al. Review: Glycation of human serum albumin. Clinica chimica acta; international journal of clinical chemistry. 2013 Oct 21;425:64-76.

Pleus, S., Freckmann, G., Schauer, S. Self-monitoring of blood glucose as an integral part in the management of people with type 2 diabetes mellitus. Diabetes Ther 13, 829–846 (2022). https://doi.org/10.1007/s13300-022-01254-8

Han JS, Lee MJ, Park KS, Han SH, Yoo TH, Oh KH, et al. Albuminuria as a risk factor for anemia in chronic kidney disease: Result from the KoreaN Cohort Study for outcomes in patients with chronic kidney disease (KNOW-CKD). PloS one. 2015;10(10):e0139747.

Neelofar K, Ahmad J. Review article : Amadori Albumin in Diabetic Ne- phropathy. Indian journal of endocrinology and metabolism. 2015;19(1):39-45.

Nathan DM, McGee P, Steffes MW, Lachin JM, Group DER. Relationship of glycated albumin to blood glucose and HbA1c values and to retinopathy, nephropathy, and cardiovascular outcomes in the DCCT/EDIC study. Diabetes. 2014 Jan;63(1):282-90.

Lee JW, Kim HJ, Kwon YS, Jun YH, Kim SK, Choi JW, Lee JE. Serum glycated albumin as a new glycemic marker in pediatric diabetes. Ann Pediatr Endocrinol Metab. 2013 Dec;18(4):208-13

Loeffler I, Wolf G. Epithelial-to-mesenchymal transition in diabetic nephropathy: fact or fiction? Cells. 2015 Oct 9;4(4):631-52. doi: 10.3390/cells4040631.

Smolock AR, Mishra G, Eguchi K, Eguchi S, Scalia R. Protein kinase C upregulates intercellular adhesion molecule-1 and leukocyte-endothelium interactions in hyperglycemia via activation of endothelial expressed. Arterioscler Thromb Vasc Biol. 2015 Feb;31(2):289-96. doi: 10.1161/ATVBAHA.110.217901. Epub 2015 Nov 15

Koga M, Murai J, Saito H, Otsuki M, Kasayama S. Evaluation of the glycated albumin/hba1c ratio by stage of diabetic nephropathy. Diabetol Int Journal. 2011;2:141-5.

Levitt DG, Levitt MD. Human serum albumin homeostasis: a new look at the roles of synthesis, catabolism, renal and gastrointestinal excretion, and the clinical value of serum albumin measurements. International Journal of General Medicine. 2016;9:229-55.

Balamir I, Ates I, Topcuoglu C, Turhan T. Association of endocan, ischemia-modified albumin, and hscrp levels with endothelial dysfunction in type 2 diabetes mellitus. Angiology. 2018;69(7):609-616.

Ahmad T, Ulhaq I, Mawani M, Islam N. Microalbuminuria in type-2 diabetes mellitus; the tip of iceberg of diabetic complications. Pak J Med Sci. 2017 May-Jun;33(3):519-523. doi: 10.12669

DOI: https://doi.org/10.26891/JIK.v17i1.2023.53-58

Refbacks

  • There are currently no refbacks.